Kingworld Medicines Group Limited provided consolidated earnings guidance for the year ended 31 December 2023. For the year, the Group is expected to record an increase in the profit of the Group attributable to owners of the Company by approximately 65% to 75% for the Year as compared to the profit of the Group attributable to owners of the Company of RMB 22.7 million for the year ended 31 December 2022 (the ?Previous Year?).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.55 HKD | +1.85% | +10.00% | -12.70% |
Apr. 23 | Kingworld Medicines Posts 68% Jump in 2023 Profit | MT |
Mar. 27 | Kingworld Medicines Group Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-12.70% | 40.87M | |
+15.94% | 70.45B | |
+2.02% | 25.03B | |
+7.11% | 8.29B | |
-2.98% | 8.05B | |
-20.55% | 7.97B | |
+3.91% | 4.62B | |
+17.12% | 4.25B | |
-1.24% | 4.04B | |
-3.44% | 3.86B |
- Stock Market
- Equities
- 1110 Stock
- News Kingworld Medicines Group Limited
- Kingworld Medicines Group Limited Provides consolidated Earnings Guidance for the Year Ended 31 December 2023